Advertisement
Screener

Arbutus Biopharma Corp (ABUS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Arbutus Biopharma Corp Cash Flow Breakdown

Cash flow breakdown shows where Arbutus Biopharma Corp's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $39.64M went out.
  • Fiscal year ended 2025-12-31: from investing, $15.58M came in.
  • Fiscal year ended 2025-12-31: from financing, $5.72M came in.
  • Fiscal year ended 2025-12-31: change in cash, $18.32M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2025-12-31-$39.64M$15.58M$5.54M-$18.32M
2024-12-31-$64.85M$22.95M$7.48M$44.52M*$10.04M
2023-12-31-$85.94M$50.77M$260.00K$30.39M*-$4.49M
2022-12-31-$35.36M-$74.94M$122.00K$31.69M*-$78.51M
2021-12-31-$67.53M-$12.68M$134.66M$2.57M*$57.03M
2020-12-31-$51.44M-$14.91M$86.30M$20.45M
2019-12-31-$71.01M$28.34M$18.60M$18.86M*-$5.14M
2018-12-31-$67.87M-$4.13M$0.00$55.65M*-$17.35M
2017-12-31-$48.64M$27.82M$100.00K$49.22M*$30.88M
2016-12-31-$57.88M-$99.12M$12.00M$0.00$637.00K*-$143.37M
2015-12-31-$56.38M$7.68M$0.00$142.18M$1.69M*$94.59M
2014-12-31-$12.42M-$42.96M$0.00$56.48M$4.20M*$3.47M
2013-12-31-$6.74M-$725.00K$32.04M$678.00K*$21.69M
2012-12-31$32.91M-$12.00K$3.84M$703.00K*$37.99M
2011-12-31-$7.83M-$60.38K$4.60M-$3.38M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$6.02M*-$1.66M*$3.15M*
2026-03-31-$8.11M$2.20M$11.53M$5.70M
2025-12-31-$4.68M*-$1.36M*$1.64M*
2025-09-30-$5.82M*-$10.02M*$794.00K*
2025-06-30-$15.75M*$15.61M*$453.00K*
2025-03-31-$13.39M$11.35M$2.65M$746.00K
2024-12-31-$10.31M*$13.41M*$1.42M*
2024-09-30-$20.74M*-$11.99M*$1.59M*
2024-06-30-$14.50M*$9.83M*$2.01M*$22.36M*
2024-03-31-$19.30M$11.69M$2.45M$21.98M*$16.82M
2023-12-31-$17.29M*$22.23M*$1.00K*$3.81M*
2023-09-30-$21.78M*$10.43M*$0.00*$1.68M*
2023-06-30-$19.56M*$1.44M*$0.00*$4.74M*
2023-03-31-$27.30M$16.68M$259.00K$20.16M*$9.80M
2022-12-31-$16.99M*$12.68M*$1.00K*$11.08M*
2022-09-30-$18.69M*-$13.74M*$0.00*$9.13M*
2022-06-30-$20.29M*-$13.83M*$113.00K*
2022-03-31$20.62M-$60.06M$8.00K$11.48M*-$27.95M
2021-12-31-$19.61M*-$8.12M*$59.24M*
2021-09-30-$16.04M*$15.97M*$44.74M*$2.22M*
2021-06-30-$14.01M*-$38.75M*$4.27M*
2021-03-31-$17.88M$18.22M$26.42M$27.17M
2020-12-31-$15.01M*-$49.98M*$20.18M*
2020-09-30-$12.17M*$14.10M*$48.76M*
2020-06-30-$8.80M*$23.37M*$5.04M*
2020-03-31-$15.45M-$2.40M$12.31M-$5.38M
2019-12-31-$13.35M*-$58.82M*$13.88M*
2019-09-30-$23.47M$16.16M$0.00$18.55M*$11.21M
2019-06-30-$17.61M$9.97M$2.48M-$5.10M
2019-03-31-$16.58M$61.03M$2.25M$47.03M
2018-12-31-$17.07M*$44.78M*$0.00*
2018-09-30-$13.20M$24.38M$0.00$11.74M
2018-06-30-$17.62M$14.98M$0.00$735.00K*-$2.27M
2018-03-31-$19.97M-$75.67M$66.27M-$11.90M*-$41.83M
2017-12-31-$10.34M*$709.00K*$34.00K*$48.87M*$39.07M*
2017-09-30-$15.68M$5.30M$61.00K-$8.99M
2017-06-30-$5.08M-$1.39M$4.00K-$5.64M
2017-03-31-$17.54M$23.20M$1.00K$6.44M
2016-12-31-$14.82M*$731.00K*$0.00*$12.00M*-$3.22M*
2016-09-30-$14.71M-$880.00K$76.00K-$16.34M
2016-06-30-$16.80M-$85.39M$0.00-$101.80M
2016-03-31-$11.55M-$13.58M$115.00K-$22.01M
2015-12-31-$18.21M*-$1.80M*$0.00*-$14.31M*
2015-09-30-$2.53M-$17.73M$0.00-$26.12M
2015-06-30-$16.67M-$10.33M$2.00K$958.00K*-$25.07M
2015-03-31-$17.84M$37.55M$142.18M$645.00K*$160.09M
2014-12-31-$6.85M*$1.06M*$0.00*-$5.99M*
2014-09-30-$6.72M-$443.00K$0.00$684.00K*-$7.09M
2014-06-30-$8.01M-$43.24M$0.00*-$49.09M
2014-03-31$9.15M-$335.00K$56.48M$2.81M*$65.64M
2013-12-31$2.57M*-$194.00K*$278.00K*$32.16M*$32.88M*
2013-09-30-$3.67M*-$120.00K*$22.00K*-$2.90M*
2013-06-30-$3.67M-$120.00K$22.00K-$2.90M
2013-03-31-$2.84M-$201.00K$82.00K-$3.90M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Apnimed, Inc. (APMD)United States$0.899B
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Savara Inc (SVRA)United States$1.044B-9.10
Theravance Biopharma, Inc. (TBPH)$0.885B16.40